Perspectives - An international review of the national cost estimates of mental illness, 1990-2003

Journal of Mental Health Policy and Economics

Volumn 9, Issue 1, 2006, Pages 3-13

  Hu, Teh Wei ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDGET; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEMENTIA; DEPRESSION; DISEASE CLASSIFICATION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; INFORMATION PROCESSING; MENTAL DISEASE; MENTAL HEALTH SERVICE; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

AUSTRALIA; CHINA; COSTS AND COST ANALYSIS; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; INTERNATIONAL COOPERATION; MENTAL DISORDERS; MENTAL HEALTH SERVICES; UNITED STATES;

EID: 33646042532     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2005.11.002     Document Type: Review

References (53)

1. Malzberg B. Mental illness and the Economic Value of Man. Ment Hyg 1950; 34: 225-227.
2. Fein R. Economics of Mental Illness: A Report to the Staff Director, Jack R. Ewalt. New York, NY: Basic Books, 1958.
3. Rice R, Kelman S,Miller I, Dunmeyer S. The Economic Costs of Alcohol and Drug Abuse and Mental Illness: 1985, U. S. Department of Health and Human Services, Public Health Service, Washington, D.C. 1990.
4. Varmus H. Evaluating the Burden of Disease and Spending the Research Dollars of the National Institutes of Health. N Engl J Med 1999; 340: 1914-1915.
5. Greenberg P, Stiglin L, Finkelstein S, Bernd E. The economic burden of depression in 1990. J Clin Psychol 1993; 54:405-418.
6. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, Ballenger JC, Fryer AJ. The Economic Burden of Anxiety Disorders in the 1990s. J Clin Psychiatry 1999; 60(7): 427-35.
7. Davies L. M., Drummond M.F. Economics and Schizophrenia: The Real Cost. Br J Psychiatry Suppl. 1994 Nov; (25): 18-21.
8. Hu T, Sandifer F. Synthesis of Cost of Illness. Georgetown University, US National Center for Health Services Research, January 1982. PB82125048. Hyattsville MD.
9. Jarvinen D, Rice D, Kelman S. Cost-of-Illness Studies: An Annotated Bibliography.San Francisco: University of California, 1988.
10. Bloom B, Bruno D, Maman D, Jayadevappa. Usefulness of US Cost-of-Illness Studies in Health Care Decision Making. Pharmacoeconomics 2001; 19(2): 207-213.
11. Berto P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo F. Depression: Cost-of-illness Studies in the International Literature, A Review. J Ment Health Policy Econ 2000; 3(1): 3-10.
12. Saxena S, Sharan P, Saraceno B. Budget and Financing of Mental Health Services: Baseline Information on 89 Countries from WHO's Project Atlas. J Ment Health Policy Econ 2003; 6(3) 135-143.
13. Jonsson B, Bebbington PE. What Price of Depression? The Cost of Depression and the Cost-effectiveness of Pharmacological Treatment. Br J Psychiatry 1994; 164: 665-673.
14. Kind P. Sorensen J. The Costs of Depression. Int J Clin Pharmacol 1993; 7(3-4): 191-195.
15. Rice DP, Miller LS. The Economic Burden of Affective Disorders. Br J Psychiatry Supplement 1995; 27 (April): 34-42
16. Yeh, Ling-Ling, Yue Chune Lee, Ming-Chin Yang, Sue-Kei Lau, Hai-Gwo Hwu. The Economic Cost of the Severely Mentally Ill Patients. Chinese Journal of Mental Health 1999; 1-15 (in Chinese).
17. Lim D, Sanderson K, Andrews G. Lost Productivity Among Full-Time Workers with Mental Disorders. J Ment Health Policy Econ 2000; 3: 139-146.
18. Andrews G, Sanderson K, Corry J, Lapsley H. Using Epidemiological Data to Model Efficiency in Reducing the Burden of Depression. J Ment Health Policy Econ 2000; 3: 175-186.
19. Sanderson K, Andrews G, Corry J, Lapsley H. Is Reducing the Burden of Affective Disorder in Evidence-based Health Care Affordable? J Affect Disord 2003; 7(2): 109-125.
20. DuPont RL, Rice DP, Miller LS, Shiraki SS, Rowland CR, Harwood HJ. Economic costs of anxiety disorders. Anxiety 1996; 2(4): 167-172.
21. Gupta RD, Guest JF. Annual cost of bipolar disorder to UK society. Br J Psychiatry 2002; 180: 227-233.
22. Rouillon F, Toumi M, Dansette GY, Benyaya J, Auquier P. Some Aspects of the Cost of Schizophrenia in France. Pharmacoeconomics 1997; 11(6): 578-594.
23. Evers SMAA, Ament AJHA. Costs of Schizophrenia in The Netherlands. Schizophr Bull 1995; 21: 141-153.
24. Knapp M. Economic Evaluation and Mental Health: Sparse Past. Fertile Future? J Ment Health Policy Econ 1999; 2(4): 163-167.
25. Rice DP, Miller LS. Health Economics and Cost Implications of Anxiety and Other Mental Disorder in the United States. Br J Psychiatry 1998; (Supplement 34): 4-9.
26. Rupp A, Harangozo J, Bognar G, Ivan N, Rado I. Economic Costs of Schizophrenia in Hungary in the 1990's. Psychiatr Hung 1999; 14 (2): 31-142 (in Hungarian).
27. Goeree R, O'Brien B, Blackhouse G, Agro K, Goering P. The Valuation of Productivity Costs Due to Premature Mortality: A Comparison of the Human-Capital and Friction-Cost Methods for Schizophrenia. Can J Psychiatry 1999; 44: 455-463.
28. Goeree R, O'Brien B, Goering P, Blackhouse G, Agro K, Rhodes A, Watson J. The Economic Burden of Schizophrenia in Canada. Can J Psychiatry 1999; 44: 464-472
29. Rund BR, Ruud T. Costs of Services for Schizophrenic Patients in Norway. Acta Psychiatr Scand 1999; 99: 120-125.
30. Tarricone R, Gerzeli S, Montaneli R, Frattura L, Percundani M, Racagani G. Direct and Indirect Costs of Schizophrenia in Community Psychiatric Services in Italy. The GISIES study. Interdisciplinary Study Group on the Economic Impact of Schizophrenia. Health Policy 2000; 51(1): 1-18.
31. Garattini L, Rossi C, Tediosi F, Cornaggia C, Covelli G, Barbui C, Parazzini F.Direct costs of schizophrenia in Italian Psychiatric services. Pharmacoeconomics 2001; 19(12): 1217-1225.
32. Haro JM, Salvador-Carulla L, Cbases J, Madoz V, Vazqyez-Barquero JL. Utilization of health care services and costs of patients with schizophrenia in three areas of Spain. Br J Psychiatry 1998: 173: 334-340.
33. Carr VJ, Neil AL, Halpin SA, Holmes S, Lewin TJ. Costs of Schizophrenia and Other Psychoses in Urban Australia: Findings from the Low Prevalence (Psychotic) Disorders Study. Aust N Z J Psychiatry 2003; 37(1): 31-40.
34. Kirigia, JM, Samba, LG. Cost of Mental and Behavioural Disorders in Kenya. Ann Gen Hosp Psychiatry 2003; 2:7 (published 10 July 2003).
35. Gray A, Fenn P. Alzheimer's Disease: The Burden of Illness in England. Health Trends 1993; 25: 31-37.
36. Scuvee-Moreau J, Kurz X, Dresse A, the NADES Group. The Economic Impact of Dementia in Belgium: Results of the National Dementia Economic Study (NADES). Acta Neurol Belg 2002; 102: 104-113.
37. Schnaider Beeri M, Werner P, Adar Z, Davidson M, Noy S. Economic Cost of Alzheimer Disease in Israel. Alzheimer Dis Assoc Disord 2002; 16(2): 73-80.
38. Rice DP, Fox PJ, Max W, Webber PA, Lindeman DA, Hauck WW, Segura E. The Economic Burden of Alzheimer's Disease Care. Health Aff 1993; 12(2): 164-176.
39. Ernst RL, Hay JW. The US Economic and Social Costs of Alzheimer's Disease Revisited. Am J Public Health 1994; 84(8): 1261-1264.
40. Hux MJ, O'Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S. Relation Between Severity of Alzheimer's Disease and Cost of Caring. Can Med Assoc J 1998; 159 (5): 457-465.
41. Souetre E, Thwaites RMA, Yeardley L. Economic Impact of Alzheimer's Disease in the United Kingdom. Cost of care and Disease Severity for Non-institutionalised Patients with Alzheimer's Disease. Br J Psychiatry 1999; 174: 51-55.
42. Cavallo MC, Fattore G. The Economic and Social Burden of Alzheimer Disease on Families in the Lombardy Region of Italy. Alzheimer Dis Assoc Disord 1997; 11(4): 184-90.
43. Hu T. Financing Global Mental Health Services. J Ment Health Policy Econ 2003; 6: 145-147.
44. Drummond M. Cost of Illness Studies. A Major Headache? Pharmacoeconomics 1992; 2: 1-4.
45. Maynard A. Economic Evaluation Techniques in Healthcare: Reinventing the Wheel? Pharmacoeconomics 1997; 11: 115-118.
46. Institute of Medicine. Scientific Opportunities and Public Needs: Improving Priority Setting and Public Input at the National Institutes of Health. National Academy Press, Washington, DC, 1988.
47. Rice DP. Estimating the cost of illness. Health Economics Series NO. 6, Public Health Service, US Government Printing Office, Washington, DC, 1966.
48. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q 1982; 60: 429-462.
49. Tediosi F, Parazzini F, Garattini L. Cost of Schizophrenia studies: a methodological review. HEPAC 2000, 1: 14-19.
50. Larson LN. Cost determination and analysis. In: Bootman JL, Townsend RJ, McGahan WF, editors. Principles of pharmacoeconomics. Cincinnati (OH): Harvey Whitney Books Co., 1996: 44-59.
51. Koopmanschap MA, Rutten FFH. A practical guide for calculating indirect costs of diseases. Pharmacoeconomics 1996; 10: 460-466.
52. Ontario Ministry of Health. Guidelines for preparation of economic analysis to be included in submission to drug programs branch for listing in the Ontario drug benefit formulary/comparative drug index. Toronto, Ministry of Health, 1991.
53. Henry D. Economic analysis as an aid to subsidization: the development of Australian guidelines of pharmaceuticals. Pharmacoeconomics 1992; 1:54-67.